Related Experiment Video
Updated: May 24, 2026

Intracranial Subarachnoidal Route of Infection for Investigating Roles of Streptococcus suis Biofilms in Meningitis in a Mouse Infection Model
Published on: July 1, 2018
Antibiotic-treated Streptococcus sanguinis intracranial mycotic aneurysm
Ya-Ting Chang1, Cheng-Hsien Lu, Chun-Chung Lui
1Department of Neurology, Chang Gung Memorial Hospital-Kaohsiung Medical Center and Chang Gung University College of Medicine, #123 Ta Pei Road, Kaohsiung, Taiwan.
Abstract:
We report the case of a woman 33 years of age with infective endocarditis-related intracranial mycotic aneurysm (IMA) caused by a Streptococcus sanguinis infection. The clinical diagnosis was confirmed by the findings of magnetic resonance imaging, magnetic resonance angiographic (MRA) studies, echocardiographic studies, and a positive blood culture result. She underwent antimicrobial treatment only (ceftriaxone intravenously for 8 weeks and penicillin V orally for 6 weeks). The regression and disappearance of IMA were demonstrated by a series of MRA follow-up studies.
Insights
A 33-year-old woman
Area of Science:
- Neuroendovascular disease
- Infectious diseases
- Cardiology
Background:
- Infective endocarditis (IE) can lead to serious complications, including intracranial mycotic aneurysms (IMAs).
- Streptococcus sanguinis is a rare cause of IE and IMA.
- Diagnosis of IMA requires a combination of imaging and microbiological studies.
Observation:
- A 33-year-old woman presented with symptoms suggestive of IE.
- Diagnostic workup revealed Streptococcus sanguinis IE with a confirmed intracranial mycotic aneurysm (IMA).
- Magnetic resonance imaging (MRI), magnetic resonance angiography (MRA), echocardiography, and blood cultures were crucial for diagnosis.
Findings:
- The patient was treated solely with antimicrobial therapy, including intravenous ceftriaxone and oral penicillin V.
- Serial MRA studies demonstrated complete regression and disappearance of the IMA.
- This case highlights the potential for non-surgical management of IE-related IMAs.
Implications:
- Antimicrobial therapy alone may be sufficient for treating certain cases of intracranial mycotic aneurysms.
- This approach avoids the risks associated with surgical or endovascular interventions.
- Further research is warranted to establish guidelines for non-surgical management of IMAs.
Related Concept Videos
Brain Abscess l: Introduction
Bacterial Meningitis I: Introduction
Aneurysm III: Interprofessional Care
Bacterial Meningitis II: Pathophysiology
Staphylococcal Skin Infections
Aneurysm II: Clinical Manifestations and Diagnostic Studies
